Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Microbiome-based therapeutics in Acute myeloid leukemia (AML) (associated infections) focus on supportive care, treatment-response modulation, and post-therapy microbiome restoration. These therapeutics are not currently used as standalone anti-leukemia drugs.
The most supported methods include:
* Fecal microbiota transplantation
* Microbiome-preserving stewardship around antibiotics
* Potential metabolite- or taxa-directed strategies
Clinical evidence in AML is still in early stages and mostly non-definitive.
Projects are: